Bcl-2-IN-14
Bcl-2-IN-14 (Compound 13c) is a BCL-2 inhibitor with an IC50 value of 0.471 μM. Bcl-2-IN-14 can be used in cancer research[1].
Product Specifications
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl-2-in-14.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(SC(NC(C2=CC=C(NCCC3=CC=CC=C3)C([N+]([O-])=O)=C2)=O)=N4)=C4C=C1)NC5=CC=C(C=C5)OCC6=CC=C(C)C=C6
Molecular Formula
C37H31N5O5S
Molecular Weight
657.74
References & Citations
[1]Ismail HS, et al. Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors. Sci Rep. 2023 Sep 20;13 (1) :15554.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PDEV100012-01 20 µg
Recombinant SARS-CoV-2 Nucleocapsid Protein (His Tag)
Sign In for Pricing
View Details PDEV100012-02 100 µg
Recombinant SARS-CoV-2 Nucleocapsid Protein (His Tag)
Sign In for Pricing
View Details PDEV100012-03 500 µg
Recombinant SARS-CoV-2 Nucleocapsid Protein (His Tag)
Sign In for Pricing
View Details PDEV100012-04 1 mg
Recombinant SARS-CoV-2 Nucleocapsid Protein (His Tag)
Sign In for Pricing
View Details 
